Literature DB >> 6144042

Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species.

D Wolf, S Admon, M Oren, V Rotter.   

Abstract

Cells of the Abelson murine leukemia virus-transformed line L12 that lack the p53 protein also lack polyadenylated mRNA capable of directing the synthesis of p53 in a cell-free system. Direct analysis of stable polyadenylated mRNA from a variety of cell lines shows that all p53 producers shared a common mRNA species (2.0 kilobases) which hybridized with a p53-specific cDNA probe. This species, which appears to be the mature, normal-sized p53 mRNA, was totally undetectable in L12 cells, which did not produce p53 in vivo. However, L12 cells contained two major p53-specific mRNA species of a substantially larger size (3.5 and 6.5 kilobases) than the p53-specific mRNA in the p53-producing cells. Genomic DNA analysis uncovered an apparent alteration in the 5' proximal part of only one p53 gene, which is unique to the L12 cell line. It is thus possible that the nonproducer phenotype of L12 cells is due at least in part to an alteration within a p53-specific DNA sequence. These findings define a system in which production of p53 appears to be efficiently regulated at the level of stable mRNA and which can be used to study the mechanisms controlling p53 expression in Abelson murine leukemia virus-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144042      PMCID: PMC368735          DOI: 10.1128/mcb.4.3.552-558.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

2.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

3.  SV40 T antigen binds specifically to a cellular 53 K protein in vitro.

Authors:  F McCormick; R Clark; E Harlow; R Tjian
Journal:  Nature       Date:  1981-07-02       Impact factor: 49.962

4.  Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.

Authors:  M Oren; N C Reich; A J Levine
Journal:  Mol Cell Biol       Date:  1982-04       Impact factor: 4.272

5.  Host nuclear proteins expressed in simian virus 40-transformed and -infected cells.

Authors:  J A Melero; S Tur; R B Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

6.  Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.

Authors:  V Rotter; O N Witte; R Coffman; D Baltimore
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

7.  Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.

Authors:  E G Gurney; R O Harrison; J Fenno
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

8.  Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents.

Authors:  V Rotter; M A Boss; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

9.  p53 transformation-related protein: detection of an associated phosphotransferase activity.

Authors:  G Jay; G Khoury; A B DeLeo; W G Dippold; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  A monoclonal antibody that recognizes B cells and B cell precursors in mice.

Authors:  R L Coffman; I L Weissman
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  15 in total

1.  p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.

Authors:  Pierre-Jacques Hamard; Dana J Lukin; James J Manfredi
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

2.  Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.

Authors:  G Shaulsky; N Goldfinger; A Ben-Ze'ev; V Rotter
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

3.  Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.

Authors:  K C Thome; A Radfar; N Rosenberg
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest.

Authors:  G G Hicks; S E Egan; A H Greenberg; M Mowat
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

5.  Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.

Authors:  D Wolf; N Harris; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

6.  Oligomerization of oncoprotein p53.

Authors:  S Kraiss; A Quaiser; M Oren; M Montenarh
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  In vitro expression of human p53 cDNA clones and characterization of the cloned human p53 gene.

Authors:  D Wolf; Z Laver-Rudich; V Rotter
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

8.  Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

Authors:  M Hsiao; J Low; E Dorn; D Ku; P Pattengale; J Yeargin; M Haas
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

Review 9.  Overexpression of p53 protein in human tumors.

Authors:  Keiji Inoue; Atsushi Kurabayashi; Taro Shuin; Yuji Ohtsuki; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

10.  Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.

Authors:  D Wolf; V Rotter
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.